EHC - Encompass Health Corporation (EHC) Q1 2024 Earnings Call Transcript
2024-04-25 14:09:10 ET
Encompass Health Corporation (EHC)
Q1 2024 Results Conference Call
April 25, 2024 10:00 AM ET
Company Participants
Mark Miller - Senior Vice President of Investor Relations & Strategic Planning
Mark Tarr - CEO, President & Director
Douglas Coltharp - Executive VP & CFO
Conference Call Participants
Kevin Fischbeck - Bank of America
A.J. Rice - UBS
Andrew Mok - Barclays
Ann Hynes - Mizuho Securities
Scott Fidel - Stephens
John Ransom - Raymond James
Pito Chickering - Deutsche Bank
Ben Hendrix - RBC Capital Markets
Brian Tanquilut - Jefferies
Jared Haase - William Blair
Presentation
Operator
Good morning, everyone, and welcome to Encompass Health's First Quarter 2024 Earnings Conference Call. [Operator Instructions]
Today's conference call is being recorded. If you have any objections, you may disconnect at this time. I will now turn the call over to Mark Miller, Encompass Health's Chief Investor Relations Officer.
Mark Miller
Thank you, operator, and good morning, everyone. Thank you for joining Encompass Health's First Quarter 2024 Earnings Call. Before we begin, if you do not already have a copy, the first quarter earnings release supplemental information and related Form 8-K filed with the SEC are available on our website at encompasshealth.com.
On Page 2 of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt and labor cost trends that could cause actual results to differ materially from our projections, estimates and expectations are discussed in the company's SEC filings including the earnings release and related Form 8-K, the Form 10-K for the year ended December 31, 2023, and the Form 10-Q for the quarter ended March 31, 2024, when filed. We encourage you to read them.
You are cautioned not to place undue reliance on the estimates, projections, guidance and other forward-looking information presented, which are based on current estimates of future events and speak only as of today. We do not undertake a duty to update these forward-looking statements.
Our supplemental information and discussion on this call will include certain non-GAAP financial measures. For such measures, reconciliation to the most directly comparable GAAP measure is available at the end of the supplemental information at the end of the earnings release and as part of the Form 8-K filed yesterday with the SEC, all of which are available on our website....
Encompass Health Corporation (EHC) Q1 2024 Earnings Call Transcript